Cargando…

Clinical significance of MLH1/MSH2 for stage II/III sporadic colorectal cancer

BACKGROUND: The development of colorectal cancer (CRC) is a complicated multistep process that involves an accumulation of mutations in tumor suppressor genes and oncogenes. In the process of DNA replication, base mismatch often occurs due to various factors leading to abnormal expression of mismatc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shui-Ming, Jiang, Bin, Deng, Youping, Huang, Shu-Liang, Fang, Ming-Zhi, Wang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883179/ https://www.ncbi.nlm.nih.gov/pubmed/31798786 http://dx.doi.org/10.4251/wjgo.v11.i11.1065

Ejemplares similares

The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers
por: Lawes, D A, et al.
Publicado: (2005)

Activity (transcription) of the genes for MLH1, MSH2 and p53 in sporadic colorectal tumours with micro-satellite instability
por: Tou, S I H, et al.
Publicado: (2004)

MSH2 and MLH1 testing
por: Kurzawski, Grzegorz, et al.
Publicado: (2008)

The association between genetic variants in hMLH1 and hMSH2 and the development of sporadic colorectal cancer in the Danish population
por: Christensen, Lise Lotte, et al.
Publicado: (2008)

Allele loss occurs frequently at hMLH1, but rarely at hMSH2, in sporadic colorectal cancers with microsatellite instability.
por: Tomlinson, I. P., et al.
Publicado: (1996)

Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients
por: Petersen, Sanne M, et al.
Publicado: (2013)

Prevalence and spectrum of MLH1, MSH2, and MSH6 pathogenic germline variants in Pakistani colorectal cancer patients
por: Rashid, Muhammad Usman, et al.
Publicado: (2019)

DNA Methylation Identifies Loci Distinguishing Hereditary Nonpolyposis Colorectal Cancer Without Germ-Line MLH1/MSH2 Mutation from Sporadic Colorectal Cancer
por: Chen, Chung-Hsing, et al.
Publicado: (2016)

Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair
por: DuPrie, Matthew L., et al.
Publicado: (2022)

Thrombocytosis portends adverse prognostic significance in patients with stage II colorectal carcinoma
por: Guo, Tianhua, et al.
Publicado: (2014)

Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer
por: Benachenhou, N, et al.
Publicado: (1999)

Mutational Analysis of Mismatch Repair Genes, hMLH1 and hMSH2, in Sporadic Endometrial Carcinomas with Microsatellite Instability
por: Kobayashi, Kanji, et al.
Publicado: (1996)

Prevalence of Pathological Germline Mutations of hMLH1 and hMSH2 Genes in Colorectal Cancer
por: Li, Dandan, et al.
Publicado: (2013)

Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome
por: Schneider, Nayê Balzan, et al.
Publicado: (2018)

Mismatch Repair Proteins and Microsatellite Instability in Colorectal Carcinoma (MLH1, MSH2, MSH6 and PMS2): Histopathological and Immunohistochemical Study
por: Ismael, Nour El Hoda S., et al.
Publicado: (2017)

Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario
por: Choi, Yun-Hee, et al.
Publicado: (2009)

UMD-MLH1/MSH2/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families
por: Grandval, Philippe, et al.
Publicado: (2013)

Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers
por: Miyakura, Yasuyuki, et al.
Publicado: (2014)

Prediction of hereditary nonpolyposis colorectal cancer using mRNA MSH2 quantitative and the correlation with nonmodifiable factor
por: Tedjasaputra, Tjahjadi Robert, et al.
Publicado: (2021)

Population carrier frequency of hMSH2 and hMLH1 mutations
por: Dunlop, M G, et al.
Publicado: (2000)

Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer
por: Haron, Nor Hasyimah, et al.
Publicado: (2019)

Prognostic Value of E-cadherin-, CD44-, and MSH2-associated Nomograms in Patients With Stage II and III Colorectal Cancer
por: Qu, Jinmiao, et al.
Publicado: (2017)

An Evaluation of the Immunohistochemical Expression of Mismatch Repair Proteins (MSH2, MSH6, MLH1, and PMS2) in Prostate Adenocarcinoma
por: Javeed, Saira, et al.
Publicado: (2022)

MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer
por: Scarpa, Melania, et al.
Publicado: (2021)

Missense mutations of MLH1 and MSH2 genes detected in patients with gastrointestinal cancer are associated with exonic splicing enhancers and silencers
por: ZHU, MING, et al.
Publicado: (2013)

Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach
por: Gille, J J P, et al.
Publicado: (2002)

BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations
por: Deihimi, Safoora, et al.
Publicado: (2017)

Risk Factors Associated with Colorectal Cancer in a Subset of Patients with Mutations in MLH1 and MSH2 in Taiwan Fulfilling the Amsterdam II Criteria for Lynch Syndrome
por: Kamiza, Abram Bunya, et al.
Publicado: (2015)

Promoter Methylation of MLH1, PMS2, MSH2 and p16 Is a Phenomenon of Advanced-Stage HCCs
por: Hinrichsen, Inga, et al.
Publicado: (2014)

Mlh1 Can Function in Antibody Class Switch Recombination Independently of Msh2
por: Schrader, Carol E., et al.
Publicado: (2003)

Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers
por: Dowty, JG, et al.
Publicado: (2012)

Novel Mutations in MLH1 and MSH2 Genes in Mexican Patients with Lynch Syndrome
por: Moreno-Ortiz, Jose Miguel, et al.
Publicado: (2016)

Expression of hMLH1 and hMSH2 proteins in ameloblastomas and tooth germs
por: Bologna-Molina, Ronell, et al.
Publicado: (2018)

Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management
por: Ramsoekh, Dewkoemar, et al.
Publicado: (2009)

Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers
por: Olschwang, Sylviane, et al.
Publicado: (2009)

Novel DNA Variants and Mutation Frequencies of hMLH1 and hMSH2 Genes in Colorectal Cancer in the Northeast China Population
por: Hu, Fulan, et al.
Publicado: (2013)

Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families
por: Thodi, Georgia, et al.
Publicado: (2010)

Identification of new genetic alterations in MLH1, MSH2 and MSH6 using IHC and HRM analysis in Lynch syndrome-suspected patients
por: Mazurek, A, et al.
Publicado: (2012)

Targeted Next-Generation Sequencing of MLH1, MSH2, and MSH6 Genes in Patients with Endometrial Carcinoma under 50 Years of Age
por: Özdemir, Taha Reşid, et al.
Publicado: (2019)

Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549
por: Hasan, Assim Khattab, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b6p808qglersdprdqnb0g32s54